Panakès Partners in CHF 9.5m round for SamanTree

The fresh capital will be used to commercialise the company's patented Histolog system, primarily the Histolog Scanner v2, which enables precise tumour removal at first surgery.

Panakès is currently investing from its Fund I, which targets €5-6m investments in European and Israeli startups and small-cap businesses. It focuses on the medical equipment sector.

Previous funding
In 2015, SamanTree raised CHF 4.5m in financing from an undisclosed source.

In June 2018, the company received a CHF 400,000 grant from the Foundation for Technological Innovation. The European Innovation Council awarded SamanTree Medical a €2.3m grant in September 2018, via its H2020 SME's Instrument Program.

Company
SamanTree initially span out from the Swiss Federal Institute of Technology. The company develops imaging modalities and data analytics for improving cancer treatment care. Founded in 2014, the company is headquartered in Lausanne, Switzerland, and employs nine people.

People
Panakès Partners – Fabrizio Landi (managing partner).
Sioux Tech Fund – Arnoud de Geus (director, new business development).
SamanTree Medical – Bastien Rachet (CEO, co-founder).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• DACH
• Healthcare
• healthcare
• Switzerland
• Venture